Bidirectional Association Identified for NAFLD and Psoriasis
MONDAY, March 21, 2022 (HealthDay News) -- There is a bidirectional association between nonalcoholic fatty liver disease (NAFLD) and psoriasis, especially for patients younger than 40 years, according to a study published online Feb. 16 in Frontiers in Immunology.
Shuo-Yan Gau, from Chung Shan Medical University in Taichung, Taiwan, and colleagues retrieved data from Taiwan's National Health Insurance Research Database to examine the bidirectional association between NAFLD and psoriasis. Patients with new-onset NAFLD and psoriasis were enrolled in two cohorts; propensity score-matched controls with no NAFLD or psoriasis were included for each comparison cohort.
The researchers observed a significantly increased risk for developing psoriasis for patients with new-onset NAFLD (hazard ratio, 1.07), while for younger patients with NAFLD, the risk was increased 1.3-fold. For new-onset psoriasis patients, the risk for developing NAFLD in the future was increased 1.28-fold compared with those without psoriasis; the risk was higher for patients in younger psoriasis subgroups younger than age 40 years versus those in older subgroups (adjusted hazard ratio, 1.55).
"Future studies should consider the mechanism influencing the pathogenesis and correlation between NAFLD and psoriasis and focus on the difference between different psoriasis severity subgroups and to what extent the severity difference would affect the bidirectional association," the authors write.
Related Posts
Extreme Heat Exposure Tied to Faster Cognitive Decline in Vulnerable Populations
FRIDAY, Aug. 25, 2023 (HealthDay News) -- Extreme heat exposure can...
Nearly Three in 10 U.S. Adults Report Insomnia
WEDNESDAY, June 29, 2022 (HealthDay News) -- Insomnia negatively impacts nearly...
Could Estrogen Help Ease the Delirium That Can Come With UTIs?
TUESDAY, Jan. 3, 2023 (HealthDay News) -- Older women with urinary tract...
Por qué la fórmula infantil casera es mala idea
MIÉRCOLES, 1 de junio de 2022 (HealthDay News) -- Si tiene problemas para...